This month marks an important milestone for PHASES with the release of the new Primary Sense CVD Risk Screening, Recall and Treatment Report, supported by a new User Guide.

Developed over several months, the report helps practices identify patients at higher risk of cardiovascular disease and highlights potential gaps in screening and current care or treatment.

Thank you to the PHASES Clinical Advisory Group, led by Professor Kim Greaves, for their work in defining the requirements for this report.

Cardiovascular disease remains one of the leading causes of illness and death in Australia. At its heart, PHASES is focused on preventing heart attacks and strokes by helping practices shift activity upstream through earlier, more targeted prevention. This includes increasing heart health screening for people at risk of CVD, and increasing recommended guideline therapy for people who already have a CVD diagnosis.

The new report equips general practice teams with practical, data-informed insights to strengthen preventive care and ensure at-risk patients receive timely recall, support and treatment. It will help practices identify gaps and act earlier, smarter and more proactively to prevent avoidable acute events.

The PHASES team will continue working closely with general practices, clinicians and partner organisations to improve population health outcomes through evidence-based insights and digital innovation.